EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic assessment in patients operated for brain metastasis from systemic tumors

Bettina Grossenbacher, Anna Lareida, Selina Moors, Patrick Roth, Zsolt Kulcsar, Luca Regli, Emilie Le Rhun, Michael Weller, Fabian Wolpert iD

Cancer Medicine · 2023

DOI: 10.1002/cam4.5928 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Bettina Grossenbacher und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Clinical Neuroscience Center, University Hospital of Zurich, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Brain Neoplasms, Neoplasm Metastasis, Central Nervous System Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Established models for prognostic assessment in patients with brain metastasis do not stratify for prior surgery. Here we tested the prognostic accuracy of the Graded Prognostic Assessment (GPA) score model in patients operated for BM and explored further prognostic factors.

Methods

We included 285 patients operated for brain metastasis at the University Hospital Zurich in the analysis. Information on patient characteristics, imaging, staging, peri‐ and postoperative complications and survival were extracted from the files and integrated into a multivariate Cox hazard model.

Results

The GPA score showed an association with outcome. We further identified residual tumor after surgery ( p = 0.007, hazard ratio (HR) 1.6, 95% confidence interval (CI) 1.1–2.3) steroid use ( p = 0.021, HR 1.7, 95% CI 1.1–2.6) and number of extracranial metastasis sites ( p = 0.009, HR 1.4, 95% CI 1.1–1.6) at the time of surgery as independent prognostic factors. A trend was observed for postoperative infection of the subarachnoid space ( p = 0.102, HR 3.5, 95% CI 0.8–15.7).

Conclusions

We confirm the prognostic capacity of the GPA score in a cohort of operated patients with brain metastasis. However, extent of resection and steroid use provide additional aid for the prognostic assessment in these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsNeoplasm MetastasisCentral Nervous System NeoplasmsHumansPrognosisMaleFemaleAdultMiddle AgedAgedAged, 80 and overKarnofsky Performance Status

Stichwörter der Autor:innen

GPAassessmentprognosisscoresurgery

Autor:innen und Institutionen

  • Department of Neurology, Clinical Neuroscience Center, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
  • Department of Neuroradiology, Clinical Neuroscience Center, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
  • Department of Neurosurgery, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.

ORCID-Profile: Fabian Wolpert

Zitieren

APA

Grossenbacher, B., Lareida, A., Moors, S., Roth, P., Kulcsar, Z., Regli, L., Le Rhun, E., Weller, M., & Wolpert, F. (2023). Prognostic assessment in patients operated for brain metastasis from systemic tumors. Cancer Medicine. https://doi.org/10.1002/cam4.5928

Vancouver

Grossenbacher B, Lareida A, Moors S, Roth P, Kulcsar Z, Regli L, et al. Prognostic assessment in patients operated for brain metastasis from systemic tumors. Cancer Medicine. 2023. doi:10.1002/cam4.5928

BibTeX
@article{Grossenbacher2023,
  author = {Grossenbacher, Bettina and Lareida, Anna and Moors, Selina and Roth, Patrick and Kulcsar, Zsolt and Regli, Luca and Le Rhun, Emilie and Weller, Michael and Wolpert, Fabian},
  title = {Prognostic assessment in patients operated for brain metastasis from systemic tumors},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.5928}
}
Kostenlos starten →